182 related articles for article (PubMed ID: 34446693)
1. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
[TBL] [Abstract][Full Text] [Related]
2. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
Chen X; Tan XR; Li SJ; Zhang XX
Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARĪ³ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
5. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.
Guo B; Cheng Y; Yao L; Zhang J; Lu J; Qi H; Chen H
Cell Signal; 2022 Feb; 90():110190. PubMed ID: 34774989
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.
Huang H; Lee SH; Sousa-Lima I; Kim SS; Hwang WM; Dagon Y; Yang WM; Cho S; Kang MC; Seo JA; Shibata M; Cho H; Belew GD; Bhin J; Desai BN; Ryu MJ; Shong M; Li P; Meng H; Chung BH; Hwang D; Kim MS; Park KS; Macedo MP; White M; Jones J; Kim YB
J Clin Invest; 2018 Dec; 128(12):5335-5350. PubMed ID: 30226474
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis.
Li Y; Cen CQ; Liu B; Zhou L; Huang XM; Liu GY
Kaohsiung J Med Sci; 2022 Sep; 38(9):869-878. PubMed ID: 35791807
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.
Sun Y; Song Y; Liu C; Geng J
Biochem Biophys Res Commun; 2019 Aug; 516(2):584-590. PubMed ID: 31239155
[TBL] [Abstract][Full Text] [Related]
9. Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes.
Chen F; Xing Y; Chen Z; Chen X; Li J; Gong S; Luo F; Cai Q
Eur J Med Res; 2024 Apr; 29(1):250. PubMed ID: 38659023
[TBL] [Abstract][Full Text] [Related]
10. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
11. Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression.
Nie Y; Zhu X; Bu N; Jiang Y; Su Y; Pan K; Li S
BMC Cancer; 2022 Mar; 22(1):265. PubMed ID: 35287604
[TBL] [Abstract][Full Text] [Related]
12. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
Huang Y; Xue B; Pan J; Shen N
Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
[TBL] [Abstract][Full Text] [Related]
13. Circ_0000064 promotes high glucose-induced renal tubular epithelial cells injury to facilitate diabetic nephropathy progression through miR-532-3p/ROCK1 axis.
Wang H; Huang S; Hu T; Fei S; Zhang H
BMC Endocr Disord; 2022 Mar; 22(1):67. PubMed ID: 35291991
[TBL] [Abstract][Full Text] [Related]
14. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
Xiao Z; Chu Y; Qin W
Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
[TBL] [Abstract][Full Text] [Related]
15. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane suppresses glioma tumorigenesis via regulating circ_0079593/miR-633/ROCK1 axis.
Cheng S; Cheng J
Brain Res; 2021 Sep; 1767():147543. PubMed ID: 34089702
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
18. Circ_0002711 knockdown suppresses cell growth and aerobic glycolysis by modulating miR-1244/ROCK1 axis in ovarian cancer.
Xie W; Liu LU; He C; Zhao M; Ni R; Zhang Z; Shui C
J Biosci; 2021; 46():. PubMed ID: 33737494
[TBL] [Abstract][Full Text] [Related]
19. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
